SCHEMBL196088

SCHEMBL196088

O=Cc1cccc([N+](=O)[O-])c1[N+](=O)[O-]

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.65
GPR35 Q9HC97 2/20 0.55
TSHR P16473 2/20 0.55
TDP1 Q9NUW8 4/20 0.48
TXNRD1 Q16881 1/20 0.43
TXNRD3 Q86VQ6 1/20 0.43
TXNRD2 Q9NNW7 1/20 0.43
MAPT P10636 1/20 0.43
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
S100A4 P26447 1/20 0.41
CA12 O43570 1/20 0.41
SOS1 Q07889 1/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
THRB P10828 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27935920 1.00 ERN1 (0.65) ERN1GPR35TSHRTDP1TXNRD1
Dimethyl Sulfoxide SCHEMBL14359713 0.91 ERN1 (0.56) ERN1GPR35TSHRTDP1TXNRD1
SCHEMBL9417632 0.87 ERN1 (0.57) ERN1GPR35TSHRTDP1MAPT
SCHEMBL9630841 0.84 ERN1 (0.56) ERN1GPR35TSHRTDP1MAPT
SCHEMBL9422617 0.82 GPR35 (0.53) ERN1GPR35TSHRTDP1MAPT
Formaldehyde SCHEMBL9404272 0.82 ERN1 (0.47) ERN1GPR35TSHRTDP1MAPT
SCHEMBL4361452 0.82 ERN1 (0.47) ERN1GPR35TSHRTDP1TXNRD1
2-Nitrobenzaldehyde SCHEMBL5654 0.81 ERN1 (0.66) ERN1TDP1MAPTALDH1A1SMN1; SMN2
2-Nitrobenzaldehyde SCHEMBL29672618 0.81 ERN1 (0.66) ERN1TDP1MAPTALDH1A1SMN1; SMN2
SCHEMBL1926046 0.80 TSHR (0.71) ERN1GPR35TSHRTDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 168 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116065155-A Preparation method and application of 2-nitrobenzaldehyde carrier system based on zeolite imidazole ester 武汉楚博士科技股份有限公司 2023-05-05 CN claimed
CN-106226292-B A kind of fast inspection card of cyano-containing pyrethroid pesticide and preparation and application 中国科学院大连化学物理研究所 2018-07-03 CN claimed
CN-107903217-A A kind of preparation method of anagrelide impurity B 湖北省宏源药业科技股份有限公司 2018-04-13 CN claimed
CN-106226292-A The fast of a kind of cyano-containing pyrethroid pesticide examines card and preparation and application 中国科学院大连化学物理研究所 2016-12-14 CN claimed
US-20140127824-A1 REAGENT METHOD AND KIT FOR THE DETECTION OF NITRO ALIPHATIC COMPOUNDS MISTRAL DETECTION LTD. (IL) 2014-05-08 US claimed
US-20130317109-A1 PROCESS FOR THE PREPARATION OF LACOSAMIDE CAMBREX KARLSKOGA AB (SE) 2013-11-28 US claimed
EP-1437749-B1 ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR RUBYCON CORP (JP) 2013-07-17 EP claimed
WO-2013001534-A1 A REAGENT METHOD AND KIT FOR THE DETECTION OF NITRO ALIPHATIC COMPOUNDS MISTRAL DETECTION LTD. (IL) 2013-01-03 WO claimed
CN-102499253-A Method for preparing composition of crosslinking nanometer silica and Schiff base copper as well as application UNIV CHINA AGRICULTURAL 2012-06-20 CN claimed
CN-100456398-C Electrolyte for driving electrolytic capacitor and electrolytic capacitor RUBYCON CORP (JP) 2009-01-28 CN claimed
WO-2007019931-A1 AGENT FOR DYEING KERATINOUS FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-02-22 WO claimed
US-20070029529-A1 Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor KOMATSU AKIHIKO 2007-02-08 US claimed
CN-1882602-A Modulation and degradation of hyaluronan synthesis in the treatment of disease MEDITECH RES LTD (AU) 2006-12-20 CN claimed
US-20040245105-A1 Electrolyte solution for driving electrolytic capacitor and electrolytic capacitor RUBYCON CORPORATION (JP) 2004-12-09 US claimed
CN-1529892-A Electrolyte for driving electrolytic capacitor and electrolytic capacitor 如碧空株式会社 2004-09-15 CN claimed
EP-1437749-A1 ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR Rubycon Corporation (JP) 2004-07-14 EP claimed
EP-1390336-A1 METHOD FOR PRODUCING AROMATIC ALDEHYDES AND KETONES BY THE CATALYTIC OXIDATION OF ALKYL-AROMATIC COMPOUNDS DSM Fine Chemicals Austria Nfg GmbH & Co KG (AT) 2004-02-25 EP claimed
WO-2002096849-A1 METHOD FOR PRODUCING AROMATIC ALDEHYDES AND KETONES BY THE CATALYTIC OXIDATION OF ALKYL-AROMATIC COMPOUNDS DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) 2002-12-05 WO claimed
EP-0562877-A2 Cell fixative and method of staining cells without destroying the cell surface ORTHO DIAGNOSTIC SYSTEMS INC. (a New Jersey corp.) (US) 1993-09-29 EP claimed
CN-116065155-A Preparation method and application of 2-nitrobenzaldehyde carrier system based on zeolite imidazole ester 武汉楚博士科技股份有限公司 2023-05-05 CN disclosed
CN-114173750-A Improving the stability of agents for treating keratin materials 汉高股份有限及两合公司 2022-03-11 CN disclosed
US-20210163731-A1 TRANSIENT POLYMER FORMULATIONS, ARTICLES THEREOF, AND METHODS OF MAKING AND USING SAME GEORGIA TECH RESEARCH CORPORATION 2021-06-03 US disclosed
CN-110420206-A Benzopyrans compounds are used to prepare the application of anti-hantaan virus drug 4TH MILITARY MEDICAL UNIV CHINESE PLA 2019-11-08 CN disclosed
EP-2914574-B1 NEW PROCESS CAMBREX KARLSKOGA AB (SE) 2019-10-02 EP disclosed
CN-109180693-A Spiro-pyrans and spirooxazine class compound and preparation method thereof 苏州健雄职业技术学院 2019-01-11 CN disclosed
CN-106226292-B A kind of fast inspection card of cyano-containing pyrethroid pesticide and preparation and application 中国科学院大连化学物理研究所 2018-07-03 CN disclosed
CN-105190416-B Liquid crystal aligning agent, liquid crystal display element obtained using same, and method for producing same 日产化学工业株式会社 2018-01-02 CN disclosed
US-9771317-B2 Process for preparing lacosamide and related compounds CAMBREX KARLSKOGA AB (SE) 2017-09-26 US disclosed
CN-106226292-A The fast of a kind of cyano-containing pyrethroid pesticide examines card and preparation and application 中国科学院大连化学物理研究所 2016-12-14 CN disclosed
US-9417226-B2 Reagent, method and kit for the detection of nitro aliphatic compounds MISTRAL DETECTION LTD (IL) 2016-08-16 US disclosed
CN-103298791-B Viral polymerase inhibitors BIOTA SCIENTIFIC MANAGEMENT PTY LTD. (AU) 2016-02-03 CN disclosed
CN-102333756-B Process for preparing nitrated aromatics and mixtures thereof BASF SE (DE) 2015-11-25 CN disclosed
US-20150299105-A1 NEW PROCESS CAMBREX KARLSKOGA AB (SE) 2015-10-22 US disclosed
EP-2914574-A2 NEW PROCESS Cambrex Karlskoga Ab (SE) 2015-09-09 EP disclosed
US-9079822-B2 Process for the preparation of nitrated aromatics and mixtures thereof BASF SE (DE) 2015-07-14 US disclosed
US-9061983-B2 Methods of inhibiting xanthine oxidase activity in a cell BAYLOR COLLEGE OF MEDICINE (US) 2015-06-23 US disclosed
US-9061983-B2 Methods of inhibiting xanthine oxidase activity in a cell BAYLOR COLLEGE OF MEDICINE (US) 2015-06-23 US disclosed
US-20150166461-A1 PROCESS FOR THE PREPARATION OF NITRATED AROMATICS AND MIXTURES THEREOF BASF SE (DE) 2015-06-18 US disclosed
CN-102499253-B Method for preparing composition of crosslinking nanometer silica and Schiff base copper as well as application UNIV CHINA AGRICULTURAL 2014-06-04 CN disclosed
WO-2014068333-A2 NEW PROCESS CAMBREX KARLSKOGA AB (SE) 2014-05-08 WO disclosed
US-20140127824-A1 REAGENT METHOD AND KIT FOR THE DETECTION OF NITRO ALIPHATIC COMPOUNDS MISTRAL DETECTION LTD. (IL) 2014-05-08 US disclosed
US-20130317109-A1 PROCESS FOR THE PREPARATION OF LACOSAMIDE CAMBREX KARLSKOGA AB (SE) 2013-11-28 US disclosed
EP-2643293-A1 PROCESS FOR THE PREPARATION OF LACOSAMIDE Cambrex Karlskoga AB (SE) 2013-10-02 EP disclosed
EP-1437749-B1 ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR RUBYCON CORP (JP) 2013-07-17 EP disclosed
EP-1460660-B1 ELECTROLYTIC CAPACITOR AND ELECTROLYTIC SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR RUBYCON CORP (JP) 2013-04-10 EP disclosed
WO-2013001534-A1 A REAGENT METHOD AND KIT FOR THE DETECTION OF NITRO ALIPHATIC COMPOUNDS MISTRAL DETECTION LTD. (IL) 2013-01-03 WO disclosed
CN-101161283-B New use of CMTM1-v17 and its antagon UNIV BEIJING 2012-07-11 CN disclosed
CN-102499253-A Method for preparing composition of crosslinking nanometer silica and Schiff base copper as well as application UNIV CHINA AGRICULTURAL 2012-06-20 CN disclosed
WO-2012069855-A1 PROCESS FOR THE PREPARATION OF LACOSAMIDE CAMBREX KARLSKOGA AB (SE) 2012-05-31 WO disclosed
US-8134013-B2 Amide compound and thrombopoietin receptor activator NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-03-13 US disclosed
CN-102333756-A Process for preparing nitrated aromatics and mixtures thereof BASF SE 2012-01-25 CN disclosed
EP-2401250-A1 METHOD FOR PRODUCING NITRATED AROMATIC COMPOUNDS AND MIXTURES THEREOF BASF SE (DE) 2012-01-04 EP disclosed
US-20110306795-A1 PROCESS FOR THE PREPARATION OF NITRATED AROMATICS AND MIXTURES THEREOF BASF SE (DE) 2011-12-15 US disclosed
EP-2389455-A1 METHODS AND COMPOSITIONS FOR IDENTIFYING A FETAL CELL Verinata Health, Inc (US) 2011-11-30 EP disclosed
CN-1993467-B Gene related with prostate disease and encoding polypeptides and its application UNIV BEIJING 2011-11-23 CN disclosed
US-20110258352-A1 Inline PCI-IOV Adapter EMULEX DESIGN & MANUFACTURING CORPORATION (US) 2011-10-20 US disclosed
US-20110027771-A1 METHODS AND COMPOSITIONS FOR CELL STABILIZATION ARTEMIS HEALTH, INC. (US) 2011-02-03 US disclosed
WO-2011014741-A1 METHODS AND COMPOSITIONS FOR CELL STABILIZATION ARTEMIS HEALTH, INC. (US) 2011-02-03 WO disclosed
US-20100304978-A1 Methods and compositions for identifying a fetal cell VERINATA HEALTH, INC. 2010-12-02 US disclosed
WO-2010097453-A1 METHOD FOR PRODUCING NITRATED AROMATIC COMPOUNDS AND MIXTURES THEREOF BASF SE (DE) 2010-09-02 WO disclosed
CN-101343368-B Method for preparing poly-rotaxane with dynamic chemical bond UNIV SHANGHAI JIAOTONG 2010-08-18 CN disclosed
WO-2010085815-A1 METHODS AND COMPOSITIONS FOR IDENTIFYING A FETAL CELL ARTEMIS HEALTH, INC. (US) 2010-07-29 WO disclosed
US-7660101-B2 Electrolytic capacitor and electrolyte solution for use in an electrolytic capacitor RUBYCON CORPORATION (JP) 2010-02-09 US disclosed
CN-100558428-C Calcitonin gene related peptide receptor antagonists BRISTOL MYERS SQUIBB CO (US) 2009-11-11 CN disclosed
US-7539006-B2 Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor RUBYCON CORPORATION (JP) 2009-05-26 US disclosed
US-20090131659-A1 AMIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2009-05-21 US disclosed
EP-2056780-A1 REDUCTIVE COLOUR REMOVAL Henkel AG & Co. KGaA (DE) 2009-05-13 EP disclosed
EP-2054012-A1 SUBSTANCES FOR DYEING KERATINOUS FIBERS Henkel AG & Co. KGaA (DE) 2009-05-06 EP disclosed
CN-100477037-C Electrolytic capacitor and electrolyte for driving electrolytic capacitor RUBYCON CORP (JP) 2009-04-08 CN disclosed
EP-2026754-A2 LIGHTENING AND/OR COLOURING AGENT COMPRISING CYCLIC UREA DERIVATIVES Henkel AG & Co. KGaA (DE) 2009-02-25 EP disclosed
CN-100456398-C Electrolyte for driving electrolytic capacitor and electrolytic capacitor RUBYCON CORP (JP) 2009-01-28 CN disclosed
EP-2012742-A1 BLEACHING AND/OR COLOURING AGENTS CONTAINING PIPERIDONES Henkel AG & Co. KGaA (DE) 2009-01-14 EP disclosed
CN-101343368-A Method for preparing poly-rotaxane with dynamic chemical bond UNIV SHANGHAI JIAOTONG (CN) 2009-01-14 CN disclosed
EP-2007343-A1 BLEACHING AGENTS CONTAINING PIPERIDONES Henkel AG & Co. KGaA (DE) 2008-12-31 EP disclosed
EP-2007344-A1 BLEACHING AND/OR COLOURING AGENT WITH IMPROVED SKIN COMPATIBILITY Henkel AG & Co. KGaA (DE) 2008-12-31 EP disclosed
WO-2008055756-A1 REDUCTIVE COLOUR REMOVAL HENKEL AG & CO. KGAA (DE) 2008-05-15 WO disclosed
CN-101161283-A New use of CMTM1-v17 and its antagon UNIV BEIJING (CN) 2008-04-16 CN disclosed
CN-100378067-C Environmental nitration method of trimethylbenzene catalyzed by sulfonate substituted by alkane containing fluorine SHANGHAI INST ORGANIC CHEM (CN) 2008-04-02 CN disclosed
WO-2008028861-A1 SUBSTANCES FOR DYEING KERATINOUS FIBERS HENKEL AG & CO. KGAA (DE) 2008-03-13 WO disclosed
WO-2008022961-A1 N-HETEROCYCLES SUPPORTED ON POLYMERS THROUGH TRIAZOLE OR TETRAZOLE LINKERS FOR ORGANOCATALYTIC APPLICATIONS INSTITUT CATALÀ D'INVESTIGACIÓ QUÍMICA (ICIQ) (ES) 2008-02-28 WO disclosed
EP-1892042-A1 Proline derivatives supported on polymers through triazole or tetrazole linkers for organocatalytic applications Institut Catala D'Investigacio Quimica (ES) 2008-02-27 EP disclosed
CN-101092630-A Synthesizing virus genome of West Nile fever, and kit for detecting virus BAIOUSAIDI BIOTECH TECH DEV CO (CN) 2007-12-26 CN disclosed
WO-2007137676-A2 LIGHTENING AND/OR COLOURING AGENT COMPRISING CYCLIC UREA DERIVATIVES HENKEL AG & CO. KGAA (DE) 2007-12-06 WO disclosed
CN-100352805-C Substituted bis-indole derivatives useful as contrast agents, pharmaceutical compositions containing them and intermediates for producing them LEUVEN K U RES & DEV (BE) 2007-12-05 CN disclosed
WO-2007131716-A2 COSMETIC AGENT COMPRISING SPECIFIC SUGAR ESTERS HENKEL AG & CO. KGAA (DE) 2007-11-22 WO disclosed
WO-2007121852-A2 LIGHTENING AND/OR COLOURING AGENTS COMPRISING AMIDINES HENKEL AG & CO. KGAA (DE) 2007-11-01 WO disclosed
WO-2007121853-A2 LIGHTENING AND/OR COLOURING AGENTS COMPRISING N,N'-OXALYLDIAZOLES AND/OR OXIMIDYLDIAZOLES HENKEL AG & CO. KGAA (DE) 2007-11-01 WO disclosed
WO-2007121851-A1 LIGHTENING AND/OR COLOURING AGENTS COMPRISING HALOGENATED KETONES HENKEL AG & CO. KGAA (DE) 2007-11-01 WO disclosed
WO-2007118618-A1 BLEACHING AGENTS CONTAINING PIPERIDONES HENKEL AG & CO. KGAA (DE) 2007-10-25 WO disclosed
WO-2007118616-A1 BLEACHING AND/OR COLOURING AGENT WITH IMPROVED SKIN COMPATIBILITY HENKEL AG & CO. KGAA (DE) 2007-10-25 WO disclosed
WO-2007118617-A1 BLEACHING AND/OR COLOURING AGENTS CONTAINING PIPERIDONES HENKEL AG & CO. KGAA (DE) 2007-10-25 WO disclosed
EP-1845090-A1 AMIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR Nissan Chemical Industries, Ltd. (JP) 2007-10-17 EP disclosed
US-7279117-B2 Electrolytic capacitor and electrolyte solution for use in an electrolytic capacitor RUBYCON CORPORATION (JP) 2007-10-09 US disclosed
US-20070171595-A1 Electrolytic capacitor and electrolyte solution for use in an electrolytic capacitor RUBYCON CORPORATION (JP) 2007-07-26 US disclosed
CN-1993467-A Gene related with prostate disease and encoding polypeptides and its application UNIV BEIJING (CN) 2007-07-04 CN disclosed
WO-2007025750-A1 AGENTS FOR THE TREATMENT OF KERATIN FIBRES CONTAINING NANOSCALE CALCIUM SALTS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-03-08 WO disclosed
US-20070043000-A1 Immunosuppresive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2007-02-22 US disclosed
WO-2007019931-A1 AGENT FOR DYEING KERATINOUS FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-02-22 WO disclosed
CN-1917921-A Calcitonin gene related peptide receptor antagonists BRISTOL MYERS SQUIBB CO (US) 2007-02-21 CN disclosed
US-20070029529-A1 Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor KOMATSU AKIHIKO 2007-02-08 US disclosed
EP-1740557-A1 UREA DERIVATIVES AS ANTAGONISTS OF THE VANILLOID RECEPTOR (VR1) Bayer HealthCare AG (DE) 2007-01-10 EP disclosed
EP-1730049-A1 COSMETIC PORTION Henkel Kommanditgesellschaft auf Aktien (DE) 2006-12-13 EP disclosed
US-7081472-B2 Substituted bis-indole derivatives useful as contrast agents, pharmaceutical compositions containing them and intermediates for producing them K. U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2006-07-25 US disclosed
CN-1761517-A Mixing device HENKEL KGAA (DE) 2006-04-19 CN disclosed
EP-1636232-A2 IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES 4 AZA Bioscience nv (BE) 2006-03-22 EP disclosed
CN-1737139-A Prostate disease related gene and its coding polypeptide and its uses UNIV BEIJING (CN) 2006-02-22 CN disclosed
CN-1730463-A The green nitration method of perfluoro alkyl sulfonic acid salt catalysis sym-trimethylbenzene SHANGHAI INST ORGANIC CHEM (CN) 2006-02-08 CN disclosed
WO-2005103018-A1 UREA DERIVATIVES AS ANTAGONISTS OF THE VANILLOID RECEPTOR (VR1) BAYER HEALTHCARE AG (DE) 2005-11-03 WO disclosed
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US disclosed
WO-2005085089-A1 COSMETIC PORTION HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2005-09-15 WO disclosed
CN-1202071-C Pollution-free nitrifying process using composite metal complex to catalyze aromatic compound SHANGHAI INST ORGANIC CHEM (CN) 2005-05-18 CN disclosed
US-20050094352-A1 Electrolytic capacitor and electrolitic solution for driving electrolytic capacitor RUBYCON CORPORATION (JP) 2005-05-05 US disclosed
US-20040245105-A1 Electrolyte solution for driving electrolytic capacitor and electrolytic capacitor RUBYCON CORPORATION (JP) 2004-12-09 US disclosed
WO-2004104005-A2 IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES 4 AZA BIOSCIENCE NV (BE) 2004-12-02 WO disclosed
EP-1479682-A1 Immunosuppressive effects of pteridine derivatives 4 AZA Bioscience nv (BE) 2004-11-24 EP disclosed
EP-1460660-A1 ELECTROLYTIC CAPACITOR AND ELECTROLITIC SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR Rubycon Corporation (JP) 2004-09-22 EP disclosed
CN-1166620-C Green nitration process of utilizing rare earth metal salt of perfluoro alkyl sulfonic acid to catalyze aromatic compound 中国科学院上海有机化学研究所 2004-09-15 CN disclosed
CN-1529892-A Electrolyte for driving electrolytic capacitor and electrolytic capacitor 如碧空株式会社 2004-09-15 CN disclosed
EP-1437749-A1 ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR Rubycon Corporation (JP) 2004-07-14 EP disclosed
EP-1434557-A1 AGENT FOR THE COLORATION OF KERATIN-CONTAINING FIBERS Henkel Kommanditgesellschaft auf Aktien (DE) 2004-07-07 EP disclosed
EP-1432428-A1 Agent for colouring fibres containing keratin Henkel Kommanditgesellschaft auf Aktien (DE) 2004-06-30 EP disclosed
CN-1494723-A Electrolytic capacitor and electrolyte for driving electrolytic capacitor 如碧空株式会社 2004-05-05 CN disclosed
CN-1486299-A Substituted bis-indole derivatives useful as contrast agents, pharmaceutical compositions containing them and intermediates for producing them ³�������̴�ѧ�о������� 2004-03-31 CN disclosed
US-6713489-B2 TREATMENT OF ATHEROSCLEROSIS, OBESITY, DIABETES, HYPERLIPIDEMIA, HYPERLIPOPROTEINEMIA, HYPERCHOLESTEROLEMIA, HYPERTRIGLYCERIDEMIA, HYPOALPHALIPOPROTEINEMIA, PANCREATITIS, MYOCARDIAL INFARCTION, STROKE, RESTENOSIS, OR SYNDROME X PFIZER INC 2004-03-30 US disclosed
EP-1399412-A1 PHOTOLABILE ESTERS AND THEIR USES The Institute of Cancer Research (GB) 2004-03-24 EP disclosed
US-20040053911-A1 Substituted bis-indole derivatives useful as contrast agents, pharmaceutical compositions containing them and intermediates for producing them K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2004-03-18 US disclosed
EP-1390336-A1 METHOD FOR PRODUCING AROMATIC ALDEHYDES AND KETONES BY THE CATALYTIC OXIDATION OF ALKYL-AROMATIC COMPOUNDS DSM Fine Chemicals Austria Nfg GmbH & Co KG (AT) 2004-02-25 EP disclosed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US disclosed
US-6657065-B2 Which are useful as microsomal triglyceride transfer protein (MTP) inhibitors PFIZER INC 2003-12-02 US disclosed
EP-1343758-A1 SUBSTITUTED BIS-INDOLE DERIVATIVES USEFUL AS CONTRAST AGENTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES FOR PRODUCING THEM K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2003-09-17 EP disclosed
WO-2003030845-A1 AGENT FOR THE COLORATION OF KERATIN-CONTAINING FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 WO disclosed
WO-2003030842-A1 AGENT FOR COLOURING FIBRES CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 WO disclosed
WO-2003000644-A1 PHOTOLABILE ESTERS AND THEIR USES THE INSTITUTE OF CANCER RESEARCH (GB) 2003-01-03 WO disclosed
WO-2002096849-A1 METHOD FOR PRODUCING AROMATIC ALDEHYDES AND KETONES BY THE CATALYTIC OXIDATION OF ALKYL-AROMATIC COMPOUNDS DSM FINE CHEMICALS AUSTRIA NFG GMBH & CO KG (AT) 2002-12-05 WO disclosed
US-20020161233-A1 Methods of making quinoline amides TOM NORMA J (US) 2002-10-31 US disclosed
CN-1373121-A Pollution-free nitrifying process using composite metal complex to catalyze aromatic compound SHANGHAI INST ORGANIC CHEM (CN) 2002-10-09 CN disclosed
CN-2513105-Y Color comparsion card for unsym-dimethyl hadrazine of personal dose MILITARY MEDICAL SCIENCE INST (CN) 2002-09-25 CN disclosed
US-20020132806-A1 7-[(4'-trifluoromethyl-biphenyl-2-carbonyl)amino]-quinoline-3-carboxylic acid amides, and methods of inhibiting the secretion of apolipoprotein B RUGGERI ROGER (US) 2002-09-19 US disclosed
US-6417367-B1 THAT ARE MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN (MTP) INHIBITORS USEFUL FOR TREATING HYPERCHOLESTEROLEMIA FOR EXAMPLE; FEWER SYNTHESIS STEPS, STARTING MATERIALS ARE AN ACYL HALIDE AND M-NITROANILINE PFIZER INC. 2002-07-09 US disclosed
WO-2002038546-A1 SUBSTITUTED BIS-INDOLE DERIVATIVES USEFUL AS CONTRAST AGENTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES FOR PRODUCING THEM K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2002-05-16 WO disclosed
US-20020042516-A1 Methods of making quinoline amides TOM NORMA J (US) 2002-04-11 US disclosed
US-6369075-B1 7[4′-trifluoromethyl-biphenyl-2-carbonyl)amino]-quinoline-3-carboxylic acid amides, and method of inhibiting the secretion of apolipoprotein B PFIZER, INC. 2002-04-09 US disclosed
CN-1310168-A Green nitration process of utilizing rare earth metal salt of perfluoro alkyl sulfonic acid to catalyze aromatic compound SHANGHAI INST ORGANIC CHEM (CN) 2001-08-29 CN disclosed
EP-1099701-A1 7-[(4'-Trifluoromethyl-biphenyl-2-carbonyl)amino]-quinoline-3-carboxylic acid amides, and methods of inhibiting the secretion of apolipoprotein B Pfizer Products Inc. (US) 2001-05-16 EP disclosed
US-6225132-B1 DERIVATIZING AGENT COMPRISING A MULTIPHOTON-EMITTING RADIOISOTOPE AND A MOIETY THAT FORMS A NON-COVALENT CHEMICAL BOND WITH AN ANALYTE OF INTEREST, SUITABLE FOR DETECTION OF THE ANALYTE OF INTEREST BIOTRACES, INC. 2001-05-01 US disclosed
US-6143895-A TETRAHYDROQUINOLINONE COMPOUND TREGA BIOSCIENCES, INC. (US) 2000-11-07 US disclosed
US-6132930-A Negative photoresist composition NITTO DENKO CORPORATION (JP) 2000-10-17 US disclosed
EP-0562877-B1 Cell fixative and method of staining cells without destroying the cell surface ORTHO DIAGNOSTIC SYSTEMS INC (US) 2000-06-14 EP disclosed
US-6048663-A HEAT RESISTANCE NEGATIVE PATTERN PHOTORESIST COATING NITTO DENKO CORPORATION (JP) 2000-04-11 US disclosed
EP-0990949-A1 Negative photoresist composition NITTO DENKO CORPORATION (JP) 2000-04-05 EP disclosed
EP-0917001-A1 NEGATIVE PHOTORESIST COMPOSITIONS AND USE THEREOF NITTO DENKO CORPORATION (JP) 1999-05-19 EP disclosed
EP-0912899-A1 ENHANCED CHROMATOGRAPHY USING MULTIPHOTON DETECTION Biotraces, Inc. (US) 1999-05-06 EP disclosed
US-5854084-A Enhanced chromatography using multiphoton detection BIOTRACES, INC. (US) 1998-12-29 US disclosed
US-5747348-A Diode laser interrogated fiber optic hydrazine-fuel sensor THE AEROSPACE CORPORATION (US) 1998-05-05 US disclosed
WO-1998010286-A1 METHODS FOR PROCESSING CHEMICAL COMPOUNDS HAVING REACTIVE FUNCTIONAL GROUPS ISIS PHARMACEUTICALS, INC. (US) 1998-03-12 WO disclosed
WO-1998008813-A1 COMBINATORIAL PROCESS FOR PREPARING SUBSTITUTED PYRROLIDINE LIBRARIES ELI LILLY AND COMPANY (US) 1998-03-05 WO disclosed
WO-1998002750-A1 ENHANCED CHROMATOGRAPHY USING MULTIPHOTON DETECTION BIOTRACES, INC. (US) 1998-01-22 WO disclosed
US-5674751-A Diode laser interrogated fiber optic hydrazine-fuel sensor system and method THE AEROSPACE CORPORATION (US) 1997-10-07 US disclosed
US-5630872-A METAL ALKOXIDES, NITRO COMPOUNDS MITSUBISHI MATERIALS CORPORATION (JP) 1997-05-20 US disclosed
US-5610393-A Diode laser interrogated fiber optic reversible hydrazine-fuel sensor system and method THE AEROSPACE CORPORATION (US) 1997-03-11 US disclosed
US-5597688-A Cell fixative and method of analyzing virally infected cells ORTHO DIAGNOSTIC SYSTEMS INC. (US) 1997-01-28 US disclosed
US-5567622-A Sensor for detection of nitrogen dioxide and nitrogen tetroxide THE AEROSPACE CORPORATION (US) 1996-10-22 US disclosed
US-5422277-A Compound for preserving intracellular morphology, compound for fixing internal components of cell, compound which facilitates transport of components across cell membranes, compound for increasing permeability of membranes ORTHO DIAGNOSTIC SYSTEMS INC. (US) 1995-06-06 US disclosed
EP-0562877-A2 Cell fixative and method of staining cells without destroying the cell surface ORTHO DIAGNOSTIC SYSTEMS INC. (a New Jersey corp.) (US) 1993-09-29 EP disclosed
EP-0247167-A4 HYDROXY AND AMINOTHIAZOLYL-BENZODIAZINONE COMPOUNDS, CARDIOTONIC COMPOSITIONS INCLUDING THE SAME, AND THEIR USES. RORER INTERNAT OVERSEAS INC (US) 1988-12-12 EP disclosed
EP-0290750-A2 Systems for the visualization of exposure to ultraviolet radiation and for the utilization of ultraviolet radiation to effect color changes XYTRONYX, INC. (US) 1988-11-17 EP disclosed
EP-0247167-A1 HYDROXY AND AMINOTHIAZOLYL-BENZODIAZINONE COMPOUNDS, CARDIOTONIC COMPOSITIONS INCLUDING THE SAME, AND THEIR USES RORER INTERNATIONAL (OVERSEAS) INC. (a Delaware corporation) (US) 1987-12-02 EP disclosed
WO-1987003199-A1 HYDROXY AND AMINOTHIAZOLYL-BENZODIAZINONE COMPOUNDS, CARDIOTONIC COMPOSITIONS INCLUDING THE SAME, AND THEIR USES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1987-06-04 WO disclosed
WO-1987003199-A1 HYDROXY AND AMINOTHIAZOLYL-BENZODIAZINONE COMPOUNDS, CARDIOTONIC COMPOSITIONS INCLUDING THE SAME, AND THEIR USES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1987-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020161233-A1 Methods of making quinoline amides CETP, MTTP, LCAT ERN1 1584/4885GPR35 2734/4885TSHR 2536/4885
US-20020042516-A1 Methods of making quinoline amides CETP, MTTP, LCAT ERN1 1584/4885GPR35 2734/4885TSHR 2536/4885
US-20150299105-A1 NEW PROCESS SLC6A11, SLC6A1, SCN11A ERN1 3443/4885GPR35 4035/4885TSHR 4395/4885
US-20070043000-A1 Immunosuppresive effects of pteridine derivatives TPMT, FKBP5, RRP15 ERN1 2748/4885GPR35 2278/4885TSHR 3976/4885
US-20040053911-A1 Substituted bis-indole derivatives useful as contrast agents, pharmaceutical compositions containing them and intermediates for producing them IDO1, IDO2, CNR1 ERN1 3250/4885GPR35 2439/4885TSHR 683/4885
US-20090131659-A1 AMIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR TEK, PTAFR, MPL ERN1 2359/4885GPR35 680/4885TSHR 46/4885
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives TPMT, FKBP5, RRP15 ERN1 2794/4885GPR35 2644/4885TSHR 3735/4885
US-20020132806-A1 7-[(4'-trifluoromethyl-biphenyl-2-carbonyl)amino]-quinoline-3-carboxylic acid amides, and methods of inhibiting the secretion of apolipoprotein B APOB, CETP, PNLIP ERN1 3804/4885GPR35 1817/4885TSHR 1883/4885
US-20130317109-A1 PROCESS FOR THE PREPARATION OF LACOSAMIDE NAAA, APEH, DNPEP ERN1 3071/4885GPR35 2735/4885TSHR 3293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.